Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Ray Sumita | Chief Legal, Comp & Admin Off | 1 | $0 | $0 | 2023-11-01 |
| Powchik Peter | Director | 4 | $0 | $0 | 2023-10-02 |
| Prime Movers Lab Fund I LP | 10% Owner | 39 | $0 | $2.15M | 2023-09-08 |
| Ogilvie Landon E | Director | 1 | $0 | $0 | 2023-06-20 |
| Smith James Alan | Director | 1 | $0 | $0 | 2023-06-20 |
| Eade Katherine A. | Director | 1 | $0 | $0 | 2023-06-20 |
| Diamandis Peter | Director | 18 | $0 | $3.2K | 2023-06-20 |
| TOLEDANO GABRIELLE B | Director | 1 | $0 | $0 | 2023-06-20 |
| HORNIG GEORGE R | Director | 3 | $0 | $0 | 2023-06-20 |
| Pesile Jason | See Remarks | 2 | $0 | $0 | 2023-03-07 |
| Paula Molina Rene | See Remarks | 2 | $0 | $0 | 2023-03-07 |
| Reese Lou | See Remarks | 16 | $607.0K | $0 | 2023-03-07 |
| Palm Ulo | See Remarks | 4 | $5.8K | $0 | 2023-03-07 |
| Hu Mei Mei | See Remarks | 15 | $607.0K | $0 | 2023-03-07 |
| Sloss Dakin | 10% Owner | 16 | $0 | $1.77M | 2023-01-23 |
| Guirakhoo Farshad | Chief Scientific Officer | 11 | $0 | $0 | 2022-08-22 |
| Chui James | Director | 3 | $96.0K | $0 | 2022-06-21 |
| BLATT GREGORY R | Director | 10 | $0 | $0 | 2022-06-21 |
| UNITED BIOMEDICAL INC | 10% Owner | 10 | $365.1K | $0 | 2022-06-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Ray Sumita | Chief Legal, Comp & Admin Of | A Award deriv | 2023-11-01 | 2024-04-29 | 425,000 | — | $0 | 425,000 | SEC↗ |
| Powchik Peter | Director | A Award deriv | 2023-10-02 | 2023-10-11 | 159,744 | — | $0 | 159,744 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-08 | 2023-09-08 | 10,349 | $1.67 | $17.3K | 3,594,122 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-08 | 2023-09-08 | 4,217 | $1.67 | $7.0K | 1,464,578 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-08 | 2023-09-08 | 2,395 | $1.67 | $4.0K | 831,658 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-08 | 2023-09-08 | 25,089 | $1.67 | $41.9K | 8,713,663 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-08 | 2023-09-08 | 5,911 | $1.67 | $9.9K | 2,053,079 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-07 | 2023-09-08 | 4,786 | $1.79 | $8.6K | 2,058,990 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-07 | 2023-09-08 | 1,939 | $1.79 | $3.5K | 834,053 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-07 | 2023-09-08 | 8,378 | $1.79 | $15.0K | 3,604,471 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-07 | 2023-09-08 | 3,413 | $1.79 | $6.1K | 1,468,795 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-07 | 2023-09-08 | 20,312 | $1.79 | $36.4K | 8,738,752 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-06 | 2023-09-08 | 892 | $1.88 | $1.7K | 1,472,208 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-06 | 2023-09-08 | 507 | $1.88 | $953 | 835,992 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-06 | 2023-09-08 | 5,308 | $1.88 | $10.0K | 8,759,064 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-06 | 2023-09-08 | 1,251 | $1.88 | $2.4K | 2,063,776 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2023-09-06 | 2023-09-08 | 2,189 | $1.88 | $4.1K | 3,612,849 | SEC↗ |
| Powchik Peter | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| Diamandis Peter | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| TOLEDANO GABRIELLE B | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| Eade Katherine A. | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| Ogilvie Landon E | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| Smith James Alan | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| HORNIG GEORGE R | Director | A Award deriv | 2023-06-20 | 2023-06-26 | 132,352 | — | $0 | 132,352 | SEC↗ |
| Diamandis Peter | Director | M Exercise deriv | 2023-04-26 | 2023-05-02 | 429,037 | — | $0 | 99,009 | SEC↗ |
| Diamandis Peter | Director | M Exercise deriv | 2023-04-26 | 2023-05-02 | 46,500 | — | $0 | 732,642 | SEC↗ |
| Diamandis Peter | Director | M Exercise | 2023-04-26 | 2023-05-02 | 429,037 | $0.57 | $244.6K | 859,641 | SEC↗ |
| Diamandis Peter | Director | M Exercise | 2023-04-26 | 2023-05-02 | 46,500 | $1.21 | $56.3K | 906,141 | SEC↗ |
| Palm Ulo | See Remarks | A Award deriv | 2023-03-07 | 2023-04-04 | 123,418 | — | $0 | 123,418 | SEC↗ |
| Paula Molina Rene | See Remarks | A Award deriv | 2023-03-07 | 2023-04-04 | 116,612 | — | $0 | 116,612 | SEC↗ |
| Pesile Jason | See Remarks | A Award deriv | 2023-03-07 | 2023-04-04 | 32,700 | — | $0 | 32,700 | SEC↗ |
| Reese Lou | See Remarks | A Award deriv | 2023-03-07 | 2023-04-05 | 61,607 | — | $0 | 61,607 | SEC↗ |
| Reese Lou | See Remarks | A Award deriv | 2023-03-07 | 2023-04-05 | 301,188 | — | $0 | 301,188 | SEC↗ |
| Reese Lou | See Remarks | A Award deriv | 2023-03-07 | 2023-04-05 | 620,000 | — | $0 | 620,000 | SEC↗ |
| Hu Mei Mei | See Remarks | A Award deriv | 2023-03-07 | 2023-04-05 | 73,928 | — | $0 | 73,928 | SEC↗ |
| Hu Mei Mei | See Remarks | A Award deriv | 2023-03-07 | 2023-04-05 | 620,000 | — | $0 | 620,000 | SEC↗ |
| Sloss Dakin | 10% Owner | S Sale | 2023-01-23 | 2023-01-25 | 405,217 | $3.35 | $1.36M | 8,764,372 | SEC↗ |
| Sloss Dakin | 10% Owner | S Sale | 2023-01-23 | 2023-01-25 | 95,475 | $3.35 | $319.8K | 2,065,027 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-12-02 | 2022-12-05 | 11,121 | $2.57 | $28.6K | 9,169,589 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-12-02 | 2022-12-05 | 2,620 | $2.57 | $6.7K | 2,160,502 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-12-01 | 2022-12-05 | 63,843 | $2.97 | $189.6K | 2,163,122 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-12-01 | 2022-12-05 | 270,964 | $2.97 | $804.8K | 9,180,710 | SEC↗ |
| Sloss Dakin | 10% Owner | S Sale | 2022-09-06 | 2022-09-08 | 5,947 | $2.40 | $14.3K | 2,226,965 | SEC↗ |
| Sloss Dakin | 10% Owner | S Sale | 2022-09-06 | 2022-09-08 | 3,934 | $2.40 | $9.4K | 1,473,100 | SEC↗ |
| Sloss Dakin | 10% Owner | S Sale | 2022-09-06 | 2022-09-08 | 2,234 | $2.40 | $5.4K | 836,499 | SEC↗ |
| Sloss Dakin | 10% Owner | S Sale | 2022-09-06 | 2022-09-08 | 25,243 | $2.40 | $60.6K | 9,451,674 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-25 | 2022-08-25 | 5,362 | $2.33 | $12.5K | 2,232,912 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-25 | 2022-08-25 | 2,014 | $2.33 | $4.7K | 838,733 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-25 | 2022-08-25 | 3,547 | $2.33 | $8.3K | 1,477,034 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-25 | 2022-08-25 | 22,757 | $2.33 | $53.0K | 9,476,917 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-24 | 2022-08-25 | 19,741 | $2.39 | $47.2K | 2,238,274 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-24 | 2022-08-25 | 7,415 | $2.39 | $17.7K | 840,747 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-24 | 2022-08-25 | 13,058 | $2.39 | $31.2K | 1,480,581 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-24 | 2022-08-25 | 83,786 | $2.39 | $200.2K | 9,499,674 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-23 | 2022-08-25 | 5,265 | $2.45 | $12.9K | 1,493,639 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-23 | 2022-08-25 | 33,785 | $2.45 | $82.8K | 9,583,460 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-23 | 2022-08-25 | 2,990 | $2.45 | $7.3K | 848,162 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-08-23 | 2022-08-25 | 7,960 | $2.45 | $19.5K | 2,258,015 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise deriv | 2022-08-22 | 2022-08-29 | 2,640 | — | $0 | 58,085 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise | 2022-08-22 | 2022-08-29 | 2,640 | $0.57 | $1.5K | 68,645 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise deriv | 2022-08-15 | 2022-08-29 | 26,005 | — | $0 | 60,725 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise | 2022-08-15 | 2022-08-29 | 26,005 | $0.57 | $14.8K | 66,005 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise deriv | 2022-07-29 | 2022-08-29 | 20,000 | — | $0 | 86,730 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise | 2022-07-29 | 2022-08-29 | 20,000 | $0.57 | $11.4K | 40,000 | SEC↗ |
| BLATT GREGORY R | Director | A Award deriv | 2022-06-21 | 2022-06-23 | 129,187 | — | $0 | 129,187 | SEC↗ |
| Powchik Peter | Director | A Award deriv | 2022-06-21 | 2022-06-23 | 129,187 | — | $0 | 129,187 | SEC↗ |
| HORNIG GEORGE R | Director | A Award deriv | 2022-06-21 | 2022-06-23 | 129,187 | — | $0 | 129,187 | SEC↗ |
| Diamandis Peter | Director | A Award deriv | 2022-06-21 | 2022-06-23 | 129,187 | — | $0 | 129,187 | SEC↗ |
| Chui James | Director | A Award deriv | 2022-06-21 | 2022-06-23 | 129,187 | — | $0 | 129,187 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | P Buy | 2022-06-16 | 2022-06-21 | 100,000 | $1.99 | $199.0K | 51,737,344 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2022-06-16 | 2022-06-21 | 100,000 | $1.99 | $199.0K | 51,737,344 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2022-06-16 | 2022-06-21 | 100,000 | $1.99 | $199.0K | 51,737,344 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-13 | 2022-06-14 | 21,811 | $2.43 | $53.0K | 2,265,975 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-13 | 2022-06-14 | 92,569 | $2.43 | $224.9K | 9,617,245 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-13 | 2022-06-14 | 14,427 | $2.43 | $35.1K | 1,498,904 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-13 | 2022-06-14 | 8,193 | $2.43 | $19.9K | 851,152 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-10 | 2022-06-14 | 28,378 | $2.80 | $79.5K | 9,709,814 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-10 | 2022-06-14 | 4,423 | $2.80 | $12.4K | 1,513,331 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-10 | 2022-06-14 | 2,512 | $2.80 | $7.0K | 859,345 | SEC↗ |
| Prime Movers Lab Fund I LP | 10% Owner | S Sale | 2022-06-10 | 2022-06-14 | 6,687 | $2.80 | $18.7K | 2,287,786 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2022-06-09 | 2022-06-10 | 10,978 | $2.72 | $29.9K | 51,637,344 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2022-06-09 | 2022-06-10 | 10,978 | $2.72 | $29.9K | 51,637,344 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | P Buy | 2022-06-09 | 2022-06-10 | 10,978 | $2.72 | $29.9K | 51,637,344 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2022-06-08 | 2022-06-10 | 10,000 | $2.95 | $29.5K | 51,626,366 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2022-06-08 | 2022-06-10 | 10,000 | $2.95 | $29.5K | 51,626,366 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | P Buy | 2022-06-08 | 2022-06-10 | 10,000 | $2.95 | $29.5K | 51,626,366 | SEC↗ |
| Guirakhoo Farshad | Chief Scientific Officer | M Exercise deriv | 2022-05-03 | 2022-05-05 | 10,000 | — | $0 | 116,730 | SEC↗ |
| Guirakhoo Farshad | Chief Scientific Officer | M Exercise | 2022-05-03 | 2022-05-05 | 10,000 | $0.57 | $5.7K | 10,000 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2022-04-27 | 2022-04-28 | 4,807 | $3.58 | $17.2K | 51,616,366 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2022-04-27 | 2022-04-28 | 4,807 | $3.58 | $17.2K | 51,616,366 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | P Buy | 2022-04-27 | 2022-04-28 | 4,807 | $3.58 | $17.2K | 51,616,366 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2022-04-26 | 2022-04-28 | 18,105 | $3.45 | $62.5K | 51,611,559 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2022-04-26 | 2022-04-28 | 18,105 | $3.45 | $62.5K | 51,611,559 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | P Buy | 2022-04-26 | 2022-04-28 | 18,105 | $3.45 | $62.5K | 51,611,559 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | P Buy | 2022-04-25 | 2022-04-27 | 8,038 | $3.37 | $27.1K | 5,193,454 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2022-04-25 | 2022-04-27 | 8,038 | $3.37 | $27.1K | 51,593,454 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2022-04-25 | 2022-04-27 | 8,038 | $3.37 | $27.1K | 51,593,454 | SEC↗ |
| Powchik Peter | Director | A Award deriv | 2022-03-31 | 2022-04-04 | 94,186 | — | $0 | 94,186 | SEC↗ |
| Palm Ulo | Chief Medical Officer | A Award deriv | 2022-03-15 | 2022-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Diamandis Peter | Director | F Tax w/h | 2022-01-24 | 2022-06-23 | 312,659 | $8.60 | $2.69M | 430,604 | SEC↗ |
| Diamandis Peter | Director | M Exercise deriv | 2022-01-24 | 2022-01-26 | 652,764 | — | $0 | 163,191 | SEC↗ |
| Diamandis Peter | Director | M Exercise | 2022-01-24 | 2022-01-26 | 652,764 | $4.12 | $2.69M | 729,687 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise deriv | 2022-01-13 | 2022-08-29 | 10,000 | — | $0 | 116,730 | SEC↗ |
| Guirakhoo Farshad | (Former) Chief Scientific Of | M Exercise | 2022-01-13 | 2022-08-29 | 10,000 | $0.57 | $5.7K | 10,000 | SEC↗ |
| HORNIG GEORGE R | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 67,953 | — | $0 | 67,953 | SEC↗ |
| Pesile Jason | See Remarks | A Award deriv | 2022-01-03 | 2022-01-11 | 51,225 | — | $0 | 51,225 | SEC↗ |
| Chui James | Director | P Buy | 2021-12-31 | 2022-01-06 | 6,000 | $5.48 | $32.9K | 14,000 | SEC↗ |
| Chui James | Director | P Buy | 2021-12-10 | 2021-12-14 | 8,000 | $7.89 | $63.1K | 8,000 | SEC↗ |
| Diamandis Peter | Director | S Sale | 2021-11-18 | 2022-06-23 | 248 | $13.00 | $3.2K | 90,499 | SEC↗ |
| Diamandis Peter | Director | J Other | 2021-11-18 | 2021-11-18 | 76,923 | — | $0 | 76,923 | SEC↗ |
| Diamandis Peter | Director | J Other | 2021-11-18 | 2021-11-18 | 76,923 | — | $0 | 0 | SEC↗ |
| BLATT GREGORY R | Director | J Other | 2021-11-16 | 2021-11-18 | 76,923 | — | $0 | 76,923 | SEC↗ |
| BLATT GREGORY R | Director | J Other | 2021-11-16 | 2021-11-18 | 76,923 | — | $0 | 0 | SEC↗ |
| Diamandis Peter | Director | C Conversion deriv | 2021-11-15 | 2022-06-23 | 21,511 | — | $0 | 0 | SEC↗ |
| Diamandis Peter | Director | C Conversion | 2021-11-15 | 2022-06-23 | 13,824 | — | $0 | 13,824 | SEC↗ |
| Diamandis Peter | Director | C Conversion | 2021-11-15 | 2022-06-23 | 13,824 | — | $0 | 13,824 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 2,361,626 | — | $0 | 0 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 1,341,050 | — | $0 | 0 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 3,570,201 | — | $0 | 0 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 15,152,627 | — | $0 | 0 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 5,625,000 | — | $0 | 0 | SEC↗ |
| Hu Mei Mei | See Remarks | C Conversion deriv | 2021-11-15 | 2021-11-15 | 384,410 | — | $0 | 0 | SEC↗ |
| Hu Mei Mei | See Remarks | C Conversion deriv | 2021-11-15 | 2021-11-15 | 6,554,643 | — | $0 | 0 | SEC↗ |
| Hu Mei Mei | See Remarks | C Conversion deriv | 2021-11-15 | 2021-11-15 | 422,696 | — | $0 | 0 | SEC↗ |
| Reese Lou | Executive Chairman | C Conversion deriv | 2021-11-15 | 2021-11-15 | 6,554,643 | — | $0 | 0 | SEC↗ |
| Reese Lou | Executive Chairman | C Conversion deriv | 2021-11-15 | 2021-11-15 | 422,696 | — | $0 | 0 | SEC↗ |
| Reese Lou | Executive Chairman | C Conversion deriv | 2021-11-15 | 2021-11-15 | 384,410 | — | $0 | 0 | SEC↗ |
| BLATT GREGORY R | Director | C Conversion deriv | 2021-11-15 | 2021-11-15 | 968,636 | — | $0 | 0 | SEC↗ |
| BLATT GREGORY R | Director | C Conversion deriv | 2021-11-15 | 2021-11-15 | 250,000 | — | $0 | 0 | SEC↗ |
| BLATT GREGORY R | Director | C Conversion deriv | 2021-11-15 | 2021-11-15 | 83,329 | — | $0 | 0 | SEC↗ |
| Diamandis Peter | Director | C Conversion deriv | 2021-11-15 | 2021-11-15 | 21,511 | — | $0 | 0 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 6,554,643 | — | $0 | 0 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | C Conversion deriv | 2021-11-15 | 2021-11-15 | 384,410 | — | $0 | 0 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 1,517,754 | — | $0 | 1,517,754 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 861,857 | — | $0 | 861,857 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 2,294,473 | — | $0 | 2,294,473 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 9,738,192 | — | $0 | 9,738,192 | SEC↗ |
| Sloss Dakin | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 3,615,038 | — | $0 | 3,615,038 | SEC↗ |
| Hu Mei Mei | See Remarks | C Conversion | 2021-11-15 | 2021-11-15 | 271,655 | — | $0 | 271,655 | SEC↗ |
| Hu Mei Mei | See Remarks | C Conversion | 2021-11-15 | 2021-11-15 | 4,212,495 | — | $0 | 4,212,495 | SEC↗ |
| Hu Mei Mei | See Remarks | C Conversion | 2021-11-15 | 2021-11-15 | 247,050 | — | $0 | 51,585,416 | SEC↗ |
| Reese Lou | Executive Chairman | C Conversion | 2021-11-15 | 2021-11-15 | 247,050 | — | $0 | 51,585,416 | SEC↗ |
| Reese Lou | Executive Chairman | C Conversion | 2021-11-15 | 2021-11-15 | 4,212,495 | — | $0 | 4,212,495 | SEC↗ |
| Reese Lou | Executive Chairman | C Conversion | 2021-11-15 | 2021-11-15 | 271,655 | — | $0 | 271,655 | SEC↗ |
| Palm Ulo | Chief Medical Officer | P Buy | 2021-11-15 | 2021-11-15 | 450 | $13.00 | $5.8K | 450 | SEC↗ |
| BLATT GREGORY R | Director | C Conversion | 2021-11-15 | 2021-11-15 | 622,516 | — | $0 | 622,516 | SEC↗ |
| BLATT GREGORY R | Director | P Buy | 2021-11-15 | 2021-11-15 | 76,923 | — | $0 | 76,923 | SEC↗ |
| BLATT GREGORY R | Director | C Conversion | 2021-11-15 | 2021-11-15 | 53,553 | — | $0 | 53,553 | SEC↗ |
| BLATT GREGORY R | Director | C Conversion | 2021-11-15 | 2021-11-15 | 160,668 | — | $0 | 160,668 | SEC↗ |
| Diamandis Peter | Director | P Buy | 2021-11-15 | 2021-11-15 | 76,923 | — | $0 | 76,923 | SEC↗ |
| Diamandis Peter | Director | C Conversion | 2021-11-15 | 2021-11-15 | 271,655 | — | $0 | 271,655 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 4,212,495 | — | $0 | 4,212,495 | SEC↗ |
| UNITED BIOMEDICAL INC | 10% Owner | C Conversion | 2021-11-15 | 2021-11-15 | 247,050 | — | $0 | 51,585,416 | SEC↗ |
| Hu Mei Mei | See Remarks | P Buy | 2021-11-12 | 2021-11-15 | 17,500 | $13.82 | $241.8K | 17,500 | SEC↗ |
| Reese Lou | Executive Chairman | P Buy | 2021-11-12 | 2021-11-15 | 17,500 | $13.82 | $241.8K | 17,500 | SEC↗ |
| Guirakhoo Farshad | Chief Scientific Officer | A Award deriv | 2021-11-11 | 2021-11-15 | 41,958 | — | $0 | 41,958 | SEC↗ |
| Palm Ulo | Chief Medical Officer | A Award deriv | 2021-11-11 | 2021-11-15 | 233,100 | — | $0 | 233,100 | SEC↗ |
| Paula Molina Rene | See Remarks | A Award deriv | 2021-11-11 | 2021-11-15 | 96,153 | — | $0 | 96,153 | SEC↗ |